Literature DB >> 26727035

Structure-based binding between protein farnesyl transferase and PRL-PTP of malaria parasite: an interaction study of prenylation process in Plasmodium.

Rani Soni1, Drista Sharma1, Sachin Patel1, Bhaskar Sharma1, Tarun Kumar Bhatt1.   

Abstract

Protein prenylation is a post-translational modification critical for many cellular processes such as DNA replication, signaling, and trafficking. It is mediated by protein farnesyltransferase by recognizing 'CAAX' motif on protein substrate. Plasmodium falciparum also possesses many such proteins with 'CAAX' motif, involved in various pathways of the parasite. The interaction studies of PfPFT with its substrate were carried out using synthetic peptides but not with full protein. Therefore, in this study, we have modeled both PfPFT and its substrate protein tyrosine phosphatase (PfPRL-PTP) followed by interaction studies using protein-protein docking and molecular dynamics simulation. Our findings provided a clear picture of interactions at atomic level between prenyltransferase and its protein substrate. We are assured that this piece of information can be extended to many other proteins of parasite containing 'CAAX' motif and that it may also lead to the development of anti-malarials based on the inhibition of prenylation-dependent pathways of parasite..

Entities:  

Keywords:  CAAX motif; Plasmodium falciparum; anti-malarials; docking; molecular dynamics simulation; p.falciparum farnesyl transferase(pfPFT); prenylation; protein tyrosine phosphatase(PTP)

Mesh:

Substances:

Year:  2016        PMID: 26727035     DOI: 10.1080/07391102.2015.1126533

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  1 in total

1.  Global proteomic analysis of prenylated proteins in Plasmodium falciparum using an alkyne-modified isoprenoid analogue.

Authors:  Kiall F Suazo; Chad Schaber; Charuta C Palsuledesai; Audrey R Odom John; Mark D Distefano
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.